Skip to main content

GIP/GLP-1 receptor agonist

Compounded Tirzepatide

Compounded tirzepatide is a dual GIP/GLP-1 receptor agonist used, under medical supervision, to support weight management in adults. It is prescribed only when medically appropriate, after a live evaluation with a licensed Florida provider.

A healthy adult outdoors on a calm, bright day.

How it works

About compounded tirzepatide

Tirzepatide acts on two gut-hormone pathways at once: GIP and GLP-1. Together they help regulate appetite and the sense of fullness, which can make it easier to eat less without fighting hunger throughout the day.

As with any GLP-1 treatment, your provider typically starts at a low dose and adjusts it gradually based on your response and tolerance. It is one part of a plan built around your health, including nutrition and activity. It is not a standalone fix, and it is prescribed only when it is right for you.

Individual results vary, and no specific outcome is promised. Treatment works best alongside changes to nutrition and activity that your provider will discuss with you.

Compounded medications are prepared by a state-licensed compounding pharmacy pursuant to a valid prescription for an individual patient. Compounded drugs are not FDA-approved; the FDA does not verify the safety, effectiveness, or quality of compounded medications.
All treatments require a valid prescription issued through a licensed telehealth evaluation. Not everyone is a candidate; medication is prescribed only when it is medically appropriate.
Treatment requires a synchronous live video consultation with a licensed provider. The online intake gathers information only; no prescription is issued based on the questionnaire alone. (Fla. Stat. § 456.47)

Safety

What to know before you start

Your provider reviews your full history and the specific risks with you during your live evaluation. The essentials are below.

Boxed warning & who should not use it

GLP-1 medications carry a boxed warning for the risk of thyroid C-cell tumors. In studies, these medications caused thyroid tumors in rodents; it is not known whether they cause such tumors, including medullary thyroid carcinoma (MTC), in people.

This treatment is generally not appropriate if you have:

  • A personal or family history of medullary thyroid carcinoma (MTC)
  • Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
  • Current pregnancy, plans to become pregnant, or breastfeeding
  • A history of pancreatitis or serious gastrointestinal disease

Side effects & what to watch for

The most common side effects affect the digestive system. Nausea is most common. Vomiting, diarrhea, constipation, and reduced appetite may also occur. These effects often ease as your body adjusts to treatment.

Less common but serious risks can include pancreatitis, gallbladder problems, kidney injury from dehydration, and allergic reactions. Your provider reviews the full risks with you before prescribing.

Seek immediate medical care for severe or persistent abdominal pain, a lump or swelling in the neck, trouble swallowing, shortness of breath, or signs of an allergic reaction.

Report suspected side effects to the FDA's MedWatch program at 1-800-FDA-1088 or fda.gov/medwatch.

Medications are dispensed by our partner pharmacy, Olympia Pharmacy, a 503A compounding pharmacy and 503B outsourcing facility (FDA-registered). Olympia Pharmacy is located at 4600 L B McLeod Rd, Orlando, Florida 32811. Your medication is compounded on a patient-specific (503A) basis, pursuant to your prescription.

Schedule a consultation with a licensed Florida provider

Answer a few quick questions to request your visit. A licensed provider will review your information and decide whether treatment may be appropriate. There is no cost to begin, and this site does not collect payment.

Book a Consultation